ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Financiere Moncey SA

Financiere Moncey SA (FMONCP)

138.80
0.00
(0.00%)
Closed January 07 11:30AM
Realtime Data

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
138.80
Bid
137.22
Ask
139.68
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
138.80
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

FMONCP Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

FMONCP - Frequently Asked Questions (FAQ)

What is the current Financiere Moncey share price?
The current share price of Financiere Moncey is 138.80 €
What is the 1 year trading range for Financiere Moncey share price?
Financiere Moncey has traded in the range of 0.00 € to 0.00 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POXELPPoxel
0.211 €
(50.07%)
26.87k
PVLPRegion Centre Val de Loire
1.62 €
(35.00%)
104
ETHMEurotech SpA
1.124 €
(29.05%)
34.12k
ALMCPPMcphy Energy
1.36 €
(19.09%)
226
LHYFEPLhyfe SA
3.54 €
(18.59%)
874
GREEHCGreen Hydrogen Systems AS
kr 2.752
(-23.51%)
76
NAVAONavamedic
kr 25.80
(-9.79%)
85
AQPCAquaporin AS
kr 20.40
(-8.93%)
228
IDEXOIDEX Biometrics ASA
kr 0.1185
(-8.00%)
48.17k
PRXAProsus NV
35.625 €
(-7.13%)
578.02k
ATOPAtos SE
0.0023 €
(-4.17%)
87.59M
TITMTelecom Italia SpA
0.244 €
(0.37%)
12.08M
ISPMIntesa Sanpaolo Spa
3.9295 €
(2.09%)
3.67M
BCPUBanco Comercial Portugues SA
0.4722 €
(2.01%)
2.97M
ENELMEnel Spa
7.03 €
(0.10%)
1.07M

Discussion

View Full Feed
rooster rooster 1 minute ago
Nope Trump didn’t tell anyone to attack the capitol
BottomBounce BottomBounce 1 minute ago
$GSAT Total Debt (mrq) $422.91M
GSAT
wallstreet1231 wallstreet1231 4 minutes ago
Let’s admit it - the penny stock market is out of favor. In favor, crypto. The stinky pinkies with reverse splits, dilution, quarterly reports etc are falling out of favor to the crypto market.

My opinion, it’s hard for a solar company with a recent reverse splits, one that is delinq
SNPW
stockinspector stockinspector 4 minutes ago
Ken can't and wouldn't give a timeline or implicit details on a podcast. It is easy to forget that detail I guess.
WDLF
BottomBounce BottomBounce 5 minutes ago
$IQST Book Value Per Share (mrq) $0.05
IQST
dinogreeves dinogreeves 6 minutes ago
https://finance.yahoo.com/news/top-3-takeaways-from-nvidias-ces-2025-keynote-044257032.html
ARBE
Ricco79 Ricco79 6 minutes ago
Agreed. Next steps are Jan. 16 and the day Thompson is fired. Good question, which will affect the stock price more?
FNMA
Wingsjr Wingsjr 8 minutes ago
You are right, closes at 2pm on the 9th.
FNMA
StockItOut StockItOut 9 minutes ago
You're years pick-n-choose-facts repeated yammering is meaningless until you address the countering claims previously put forward that evidence that your claim is bullshit; the countering claims that evidence holes of your claim.
XERI
dinogreeves dinogreeves 10 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/7/eyxgi60C294F9-6D08-4187-898D-D2A4E74ACC81.webp
ARBE
wadegarret wadegarret 10 minutes ago
GERN- only one reason I'm even playing this one

I feel strongly that a partnership or buyout will happen within a few months. This is one of the most insane stories out there. Institutions love the stock, and keep buying millions of shares each quarter, while the stock keeps se
GERN
TheHound TheHound 10 minutes ago
Crazy bullish potential!
XRPUSD
Kick Up Kick Up 11 minutes ago
Lakota, it sounded to me like a lot was said that needs to be examined. I was left wondering about tokens, new companies, and future growth. Lots that can be coming, from my reading between the lines. As you said, 2025 is just getting started!
WDLF
4retire 4retire 12 minutes ago
I don’t know why I responded to you. I thought I had you on ignore. You’re too much work and my previous posts with you just left me bored and frustrated. There’s always two ways something can be interpreted. Yours is almost always negative. I see JetMek wearing himself out countering your rumors
NVDA
meshcan meshcan 14 minutes ago
If it is 2.5B market size for generic Vyvanse then still 10% of it is $250M revenue and if still $4.3B then 10% is way higher. So, regardless we will see $2 PPS by next year this time.

GLTA
ELTP
DJPele DJPele 15 minutes ago
Perfect, thanks!
NWBO
zerosnoop zerosnoop 17 minutes ago
So a U.S. government-supported financial institution specializing in global trade financing is backing the PROVEN AOT as per the FACTS in the RECENT PR below.


https://www.accesswire.com/959008/qs-energy-announces-milestones-in-global-sales-activity-and-strategic-partnerships-a
QSEP
ducci1 ducci1 18 minutes ago
Pivot Calcs: SPX Pivot--5985----R1--6010----R2--6046----S1--5949----S2--5924-----SPY Pivot--596----R1--599----S1--592-----VIX Pivot--16.20 !!LOL!!
SPY
Lakota-45 Lakota-45 18 minutes ago
A Notice to the Board; The INQD / Indoor Harvest, Security Details was updated
again today at OTC Markets, Monday, January 6, 2025 !!!
Note: ( No change on the OS ) !!!

~ ( Could it be that Q 1, 2 & 3 will be out - SOON ? )

Note; INQD has been downgraded
INQD WDLF
nowwhat2 nowwhat2 18 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/6/dirggxrp_!_6_snip_10am_LOOK_AT_IT_GO.jpg



JAN 2nd
https://investorshub.advfn.com/uimage/uploads/2025/1/6/sfkzzxrp_!_2_30d_11pm_calvin.jpg




4 DAYS LATER.....
https:
XRPUSD
skitahoe skitahoe 18 minutes ago
I believe when you submit an NDA or BLA to the FDA they make the decision whether to treat it with priority review, or not. If you get a PDUFA that's 6 months after they accept it, they gave priority review.

I believe that Alzheimer's is a sufficiently serious problem that it will be
AVXL
ATLnsider ATLnsider 20 minutes ago
Poly-ICLC is not a complementary immunotherapy agent, it is a synergistic agent.

It is an immune-boosting agent, and it will be used to improve the formulation and potency of both DCVax-L and DCVax-Direct. Here is an excerpt from the NWBio 10-Q :

entered into a contrac
NWBO
boston745 boston745 23 minutes ago
Proposal No. 1: Passed
65,138 votes for. 0 votes against

Proposal No. 2: This proposal was ratified
418k votes for Independent accounting firm

Proposal No. 3: non-binding resolution approving the compensation of the Company’s named executive officer - This
SINT

Your Recent History

Delayed Upgrade Clock